There are no studies completed to back up that claim, CV. In fact, Burt says this--
Quote:
As there are no completed randomized studies on HSCT for MS, the final results of both randomized trials – MIST, that compares cyclophosphamide/rATG as a second-line therapy for interferon/copaxone failures and the BEAM/ATG regimen as a predominantly third-line therapy as proposed in this issue of Multiple Sclerosis Journal – will be important to evaluate medium- and long-term outcome of both regimens, including their toxicity.
The evaluation of HSCT is far from over. We know it doesn't work in progressive MS, and we have people on here, like Chris, who have had this HSCT in RRMS, and continue to progress.
It is wrong and misleading to call this a cure. It may help some people find stability for awhile...but as Harry said earlier, his wife went 20 years without MS progression with NO treatment. Until we understand why gray matter atrophies in pediatric MS, CIS and continues to atrophy-we are no closer to a cure.
MS is not about inflammation. It is about gray matter atrophy and axonal loss. I've provided links to research which backs this up in my other posts.
cheer
I think Chris actually was progressive or secondary progressive when he had the treatment. He was no longer walking unassisted so I believe the treatment may not have had as beneficial effect on him as in others with RRMS. However the benefits he has received have been tracked as he has not progressed at all since having the treatment and has remained stable.
Login
Register
FAQ
Search
